Delivery Order SPE2DB22D1106-SPE2DB25FFGA4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL quantities. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $22,901.40 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension in 6 ml quantities. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 15, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child order under a larger contracting vehicle. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a delivery order valued at $3,816.90 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,804.40 firm fixed-price delivery order is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a specialty medication, with a performance period through December 11, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle...
- This is a $22,820.10 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a completion date of June 3, 2024. The contract was competitively awarded and is a firm fixed-price type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is a delivery order with a firm fixed price of $7,869.62 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of 4566640318 - CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 6, 2024. The contract was issued by the Defense Logistics Agency (DLA), a defense agency that provides...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $15,267.60, is a Delivery Order with a Firm Fixed Price pricing type. The award is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and does not have a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $3,803.35. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award, valued at $7,606.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a completion date of September 19, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGA4Delivery Order
The Defense Logistics Agency awarded a $59,619.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 MG-600 MG suspension (4 mL), a long-acting injectable antiretroviral medication. The contract, issued on August 29, 2025, with ultimate completion by September 22, 2025, represents a non-competitive, non-set-aside award leveraging the vendor's existing DLA contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with this delivery order fulfilling the Defense Health Agency's pharmaceutical supply requirements for military healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products, specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs worldwide. The contract demonstrates DLA's reliance on established prime vendors to efficiently deliver specialized medications essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.6k | 8/29/25 |